awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28067148-FD3B8B1D-F507-44AE-BD84-370BD2D576E0
Q28067148-FD3B8B1D-F507-44AE-BD84-370BD2D576E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067148-FD3B8B1D-F507-44AE-BD84-370BD2D576E0
A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma
P2860
Q28067148-FD3B8B1D-F507-44AE-BD84-370BD2D576E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067148-FD3B8B1D-F507-44AE-BD84-370BD2D576E0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f115524f4d69e7931a3181e2ff19e05940ba0584
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.